GeoVax Labs (GOVX) Competitors $0.75 +0.00 (+0.15%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GOVX vs. JSPR, STTK, TELO, KLRS, TPST, KLTO, NBRV, XFOR, ATHE, and GRCEShould you be buying GeoVax Labs stock or one of its competitors? The main competitors of GeoVax Labs include Jasper Therapeutics (JSPR), Shattuck Labs (STTK), Telomir Pharmaceuticals (TELO), Kalaris Therapeutics (KLRS), Tempest Therapeutics (TPST), Klotho Neurosciences (KLTO), Nabriva Therapeutics (NBRV), X4 Pharmaceuticals (XFOR), Alterity Therapeutics (ATHE), and Grace Therapeutics (GRCE). These companies are all part of the "pharmaceutical products" industry. GeoVax Labs vs. Its Competitors Jasper Therapeutics Shattuck Labs Telomir Pharmaceuticals Kalaris Therapeutics Tempest Therapeutics Klotho Neurosciences Nabriva Therapeutics X4 Pharmaceuticals Alterity Therapeutics Grace Therapeutics Jasper Therapeutics (NASDAQ:JSPR) and GeoVax Labs (NASDAQ:GOVX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership. Which has preferable valuation & earnings, JSPR or GOVX? GeoVax Labs has higher revenue and earnings than Jasper Therapeutics. Jasper Therapeutics is trading at a lower price-to-earnings ratio than GeoVax Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJasper TherapeuticsN/AN/A-$71.27M-$6.01-0.47GeoVax Labs$3.95M3.01-$24.99M-$2.01-0.37 Does the media favor JSPR or GOVX? In the previous week, Jasper Therapeutics had 2 more articles in the media than GeoVax Labs. MarketBeat recorded 3 mentions for Jasper Therapeutics and 1 mentions for GeoVax Labs. GeoVax Labs' average media sentiment score of 1.88 beat Jasper Therapeutics' score of 0.70 indicating that GeoVax Labs is being referred to more favorably in the news media. Company Overall Sentiment Jasper Therapeutics Positive GeoVax Labs Very Positive Do analysts recommend JSPR or GOVX? Jasper Therapeutics currently has a consensus price target of $28.75, indicating a potential upside of 926.79%. GeoVax Labs has a consensus price target of $8.50, indicating a potential upside of 1,040.02%. Given GeoVax Labs' stronger consensus rating and higher possible upside, analysts clearly believe GeoVax Labs is more favorable than Jasper Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jasper Therapeutics 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.60GeoVax Labs 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, JSPR or GOVX? Jasper Therapeutics has a beta of 2.7, meaning that its stock price is 170% more volatile than the S&P 500. Comparatively, GeoVax Labs has a beta of 3.27, meaning that its stock price is 227% more volatile than the S&P 500. Do insiders & institutionals have more ownership in JSPR or GOVX? 79.9% of Jasper Therapeutics shares are held by institutional investors. Comparatively, 6.1% of GeoVax Labs shares are held by institutional investors. 4.6% of Jasper Therapeutics shares are held by company insiders. Comparatively, 1.2% of GeoVax Labs shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is JSPR or GOVX more profitable? Jasper Therapeutics has a net margin of 0.00% compared to GeoVax Labs' net margin of -403.88%. Jasper Therapeutics' return on equity of -172.28% beat GeoVax Labs' return on equity.Company Net Margins Return on Equity Return on Assets Jasper TherapeuticsN/A -172.28% -128.34% GeoVax Labs -403.88%-408.80%-279.89% SummaryGeoVax Labs beats Jasper Therapeutics on 8 of the 15 factors compared between the two stocks. Get GeoVax Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GOVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GOVX vs. The Competition Export to ExcelMetricGeoVax LabsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.86M$3.08B$5.69B$9.86BDividend YieldN/A2.29%3.99%4.02%P/E Ratio-0.3720.7879.6626.58Price / Sales3.01392.01536.52112.00Price / CashN/A44.0537.7059.65Price / Book4.148.0710.576.59Net Income-$24.99M-$53.98M$3.27B$265.83M7 Day Performance-3.17%-0.88%0.61%0.18%1 Month Performance-0.79%5.67%5.43%2.13%1 Year Performance-84.94%9.07%50.37%21.07% GeoVax Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GOVXGeoVax Labs1.978 of 5 stars$0.75+0.1%$8.50+1,040.0%-85.1%$11.86M$3.95M-0.3710Positive NewsJSPRJasper Therapeutics3.0238 of 5 stars$2.96+1.0%$28.75+871.3%-85.8%$48.10MN/A-0.4920STTKShattuck Labs3.4813 of 5 stars$0.99+3.5%$7.00+604.4%-70.9%$47.60M$5.72M-0.82100TELOTelomir Pharmaceuticals2.4743 of 5 stars$1.46+0.7%$15.00+927.4%-71.0%$47.13MN/A-2.701News CoverageGap DownKLRSKalaris Therapeutics0.7725 of 5 stars$2.51flat$3.00+19.5%N/A$46.94MN/A0.00110Positive NewsTPSTTempest Therapeutics2.0727 of 5 stars$10.57+5.5%$30.00+183.8%-43.5%$46.93MN/A-0.7220News CoveragePositive NewsKLTOKlotho NeurosciencesN/A$0.75+0.7%N/AN/A$46.28MN/A-1.68N/APositive NewsNBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070XFORX4 Pharmaceuticals4.0788 of 5 stars$3.97+1.3%$71.17+1,692.6%-80.1%$45.29M$32.77M-0.2780Analyst ForecastGap DownATHEAlterity Therapeutics2.5803 of 5 stars$5.10+1.6%$12.00+135.3%+256.0%$45.24MN/A0.0010GRCEGrace Therapeutics2.4978 of 5 stars$3.25flat$12.00+269.2%N/A$44.95MN/A-3.78N/A Related Companies and Tools Related Companies JSPR Competitors STTK Competitors TELO Competitors KLRS Competitors TPST Competitors KLTO Competitors NBRV Competitors XFOR Competitors ATHE Competitors GRCE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GOVX) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeoVax Labs Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeoVax Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access